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Background
Severe degenerative calcific aortic stenosis (cAS) affects
3% of the over 75 year-olds and leads to heart failure
and death unless the valve is replaced. Coexisting car-
diac amyloid - typically wild-type Transthyretin
(wtATTR) has been reported but has not been systema-
tically studied: its prevalence and prognostic significance
are unknown. Multiparametric CMR (function, LGE, T1
and ECV mapping) has high sensitivity and specificity
for cardiac amyloidosis. We sought, in cAS, to define
the prevalence of occult cardiac amyloid by biopsy, sub-
type it, explore its CMR presentation and understand its
prognostic significance.
Methods
As part of the RELIEF-AS study (NCT 02174471), 146
patients with severe AS awaiting aortic valve replace-
ment (AVR) underwent CMR (LGE, T1 mapping) and
intra-operative myocardial biopsies. 108 patients had
calcific AS (cAS) [75 ± 6 years; 58% male]; the remain-
der had bicuspid (36), rheumatic (1) or unicuspid AS
(1). Biopsies were screened for cardiac amyloid by
congo red staining; if positive, tissue was fully sub-
typed (immunohistochemistry, mass spectrometry as
needed), and patients underwent full clinical amyloid
assessment including genotyping and DPD (bone tra-
cer) scintigraphy.
Results
Myocardial biopsy identified amyloid depositions in 6
out of 108 cAS patients (all age >65 years); none in the
other cohorts. All were TTR. All were by genotyping
wild-type. Two had definite cardiac amyloidosis by CMR
and DPD, but were not recognized by routine pre-
operative work-up (Figure 1). Four other patients had
findings by multiparametric CMR that could be
explained solely by severe AS (Table 1). At median fol-
low-up of 1.9 years (0.4-4.2 years), 50% of the affected
patients had died compared to 7.8% in the remaining
cAS cohort. This was highly significant and, of all para-
meters assessed, the presence of TTR amyloid had the
highest hazard ratio for death (HR 9.4 [2.4-35.6], p =
0.001, univariable Cox regression analysis).
Conclusions
Occult cardiac amyloid (wild-type TTR) has a preva-
lence of 6% in cAS undergoing surgical AVR (mean age
75). It has a poor outcome even when at low levels of
infiltration. Multiparametric CMR becomes diagnostic
in 1/3, but early disease looks like the changes of AS -
here, DPD scanning adds value.
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Figure 1 Occult Transthyretin Amyloid Deposition in Aortic Stenosis; detected by CMR late gadolinium enhancement (LGE),
histological congo red staining and DPD scintigraphy; Transthyretin deposits are associated with poor outcome in aortic stenosis
(Kaplan-Meier-Plot).
Table 1 Pre-operative characteristics of patients with TTR on cardiac biopsy
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
Age/Gender 73 female 69 male 80 female 85 male 84 male 71 male
Biopsy/Genotype TTR/wild-type TTR/wild-type TTR/wild-type TTR/wild-type TTR/wild-type TTR/wild-type
CMR LGE pattern* Amyloidosis Amyloidosis AS AS AS AS
ECV 60% 52% 31% 25% 32% 32%
LV mass index (g/m2) 137 150 117 101 93 132
DPD Scintigraphy Grade 2 Grade 2 NA Grade 1 NA Grade 1
Peak AV Gradient (mmHg) 74 45 70 110 61 116
AVAi (cm2/m2) 0.36 0.52 0.6 0.34 0.35 0.24
Follow-up Status Alive Dead Dead Alive Dead Alive
*LGE pattern consistent with diagnosis of cardiac amyloidosis / aortic stenosis (AS)
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